Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis

Author:

Mektebi Ammar,Elsaid Mohamed,Yadav Tularam,Abdallh Fatima,Assker Mohamad,Siddiq Abdelmonem,Sayad Reem,Saifi Motaz,Farahat Ramadan Abdelmoez

Abstract

Abstract Introduction Mpox is a zoonotic viral disease that emerged in May 2022 and has since shown a high prevalence in non-mpox-endemic areas, resulting in an outbreak that caused more than 84,000 cases in 110 countries around the globe. Several vaccines are available to prevent the disease, and multiple studies have been conducted to assess the attitudes of different populations toward receiving the mpox vaccine. This study systematically reviews all the studies conducted on mpox vaccine acceptance/hesitancy among healthcare workers. Methods A systematic literature search was conducted through four electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar, up to March 2023. Studies that described mpox vaccine acceptance/hesitancy among healthcare workers were included, and the data were extracted using a uniform extraction sheet. Following the extraction, the meta-analysis included ten studies with 7322 healthcare workers. Three researchers independently assessed the risk of bias in the included study using the Newcastle–Ottawa Scale (NOS). Results Ten studies were included in the review. This review indicates that the prevalence of mpox vaccine acceptance was 58.5%, and the prevalence of mpox vaccine hesitancy was 41.5%. There was a higher prevalence of acceptance in countries located in Asian and African areas compared to those in North America and Europe, estimated at 68% and 44.3%, respectively. Among the studies conducted solely among physicians, there was a high prevalence of mpox vaccine acceptance, at 77.1%, compared to 49% in studies that included all healthcare workers. Conclusion There is a significant variation in the prevalence of mpox vaccine acceptance among different populations. Further research is needed to identify the factors that contribute to this variation and to develop interventions to increase vaccine acceptance. In addition, it is important to promote research on mpox vaccine acceptance and hesitancy among healthcare workers in countries where data is limited. This research will help policymakers develop effective policies to increase acceptance and reduce the disease burden.

Publisher

Springer Science and Business Media LLC

Reference50 articles.

1. Is pandemic finally over? We asked the experts. – Harvard Gazette. https://news.harvard.edu/gazette/story/2022/10/is-pandemic-finally-over-we-asked-the-experts/ (Accessed 7 May 2023).

2. Emergencies: International health regulations and emergency committees. https://www.who.int/news-room/questions-and-answers/item/emergencies-international-health-regulations-and-emergency-committees (Accessed 7 May 2023).

3. Sah R, et al. Public health emergency of international concern declared by the World Health Organization for Monkeypox. 2022; 7(1): 51–56 https://doi.org/10.1080/23779497.2022.2124185.

4. Alakunle E, Moens U, Nchinda G, and Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses.2020; 12(11):1257 https://doi.org/10.3390/V12111257.

5. Petersen E, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027–43. https://doi.org/10.1016/J.IDC.2019.03.001.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3